Gordian Biotechnology
Gordian Biotechnology, located in South San Francisco, is dedicated to discovering new therapies for complex age-related diseases through its proprietary in vivo drug discovery platform. By utilizing innovative methods such as Patient Avatars and Mosaic Screening, the company aims to identify targets and therapies that are most likely to succeed in human trials.
With a mission to enhance the quality of life for individuals facing age-related challenges, Gordian's Pythia approach examines the entire transcriptome to assess the effects of various therapies on cellular pathways. Led by CEO Francisco LePort, the company is committed to enabling people to lead longer, healthier lives.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.